Again, we did not identify any obvious DSBs in these tumor cells, suggesting that under the low dose treatment of DNA-PK-i and PARP-i, it is ribosome biogenesis impairment but not induced DSBs suppress BRCA1-deficient tumor cell growth. Here, BRCA1 is linked to neoplasm.